ArticleBrazilian journal of otorhinolaryngology2026
Is the magnetic resonance imaging contrast agent gadoteric acid ototoxic?
Article in Brazilian journal of otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveContrast Magnetic Resonance Imaging (MRI) reveals endolymphatic hydrops in both symptomatic and asymptomatic ears. Radiological visualization of hydrops is important in the diagnosis of Meniere's disease; however, the ototoxicity of intratympanically administered gadoteric acid remains unknown. To investigate the ototoxicity of the intratympanic administration of gadoteric acid at different doses using an Auditory Brainstem Response (ABR) test and histopathological methods.
methodsForty healthy male Wistar Albino rats were randomly divided into four groups. The effect of different dilutions of gadoteric acid on the inner ear was examined using the ABR test at 10, 16, and 24 kHz. Basal measurements were compared with those at 1 and 14 days after injection. After completing the final measurements, the rats were sacrificed, and samples were taken for histopathological examination under light microscopy.
resultsFollowing the intratympanic administration of gadoteric acid in rats, the ototoxicity was evaluated on days-1 and -14 based on ABR testing and histopathological examination. The ABR measurements demonstrated that pure gadoteric acid caused a significant decrease in the hearing threshold at 10, 16, and 24 kHz. By contrast, threshold shifts were not significant with diluted preparations. Histopathological examination revealed no significant differences.
conclusionOtotoxicity was detected on day-14 following the intratympanic administration of undiluted gadoteric acid, determined by ABR testing. The dilution of gadoteric acid with saline at a 1:16 ratio appeared to be the safest dose. The level of evidence of this article is 5. This article is an experimental animal and laboratory study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.